Abstract:Aims: Chronic and excessive alcohol consumption is a high-risk factor for osteoporosis. Bone marrow-derived mesenchymal stem cells (BM-MSCs) play an important role in bone formation; however, they are vulnerable to ethanol (EtOH). The purpose of this research was to investigate whether EtOH could induce premature senescence in BM-MSCs and subsequently impair their osteogenic potential. Methods: Human BM-MSCs were exposed to EtOH ranging from 10 to 250 mM. Senescence-associated beta-galactosidase (SA-beta-gal) activity, cell cycle distribution, cell proliferation and reactive oxygen species (ROS) were evaluated. Mineralization and osteoblast-specific gene expression were evaluated during osteogenesis in EtOH-treated BM-MSCs. To investigate the role of silent information regulator Type 1 (SIRT1) in EtOH-induced senescence, resveratrol (ResV) was used to activate SIRT1 in EtOH-treated BM-MSCs. Results: EtOH treatments resulted in senescence-associated phenotypes in BM-MSCs, such as decreased cell proliferation, increased SA-beta-gal activity and G0/G1 cell cycle arrest. EtOH also increased the intracellular ROS and the expression of senescence-related genes, such as p16(INK4 alpha) and p21. The down-regulated levels of SIRT1 accompanied with suppressed osteogenic differentiation were confirmed in EtOH-treated BM-MSCs. Activation of SIRT1 by ResV partially counteracted the effects of EtOH by decreasing senescence markers and rescuing the inhibited osteogenesis. Conclusion: EtOH treatments induced premature senescence in BM-MSCs in a dose-dependent manner that was responsible for EtOH-impaired osteogenic differentiation. Activation of SIRT1 was effective in ameliorating EtOH-induced senescence phenotypes in BMSCs and could potentially lead to a new strategy for clinically preventing or treating alcohol-induced osteoporosis. Short summary: Ethanol (EtOH) treatments induce premature senescence in marrow-derived mesenchymal stem cells in a dose-dependent manner that is responsible for EtOH-impaired osteogenic differentiation. Activation of SIRT1 is effective in ameliorating EtOH-induced senescence phenotypes, which potentially leads to a new strategy for clinically treating alcohol-induced osteoporosis.

Alcohol-induced inhibition of bone formation and neovascularization contributes to the failure of fracture healing via the miR-19a-3p/FOXF2 axis

miR-136-3p targets PTEN to regulate vascularization and bone formation and ameliorates alcohol-induced osteopenia

miR‐4286 functions in osteogenesis and angiogenesis via targeting histone deacetylase 3 and alleviates alcohol‐induced bone loss in mice

Chronic High Dose Alcohol Induces Osteopenia Via Activation of Mtor Signaling in Bone Marrow Mesenchymal Stem Cells.

Alcoholism and Osteoimmunology

Osthole Stimulates Bone Formation, Drives Vascularization and Retards Adipogenesis to Alleviate Alcohol‐induced Osteonecrosis of the Femoral Head

Cellular and Molecular Mechanisms of Alcohol-Induced Osteopenia

The Role and Mechanism of Tumor Necrosis Factor-Alpha in Alcohol-Induced Bone Loss.

The Protective Effect of PFTα on Alcohol-Induced Osteonecrosis of the Femoral Head

Betaine Alleviates Alcohol-Induced Osteonecrosis of the Femoral Head Via Mtor Signaling Pathway Regulation.

Alcohol Induces Cellular Senescence and Impairs Osteogenic Potential in Bone Marrow-Derived Mesenchymal Stem Cells.

Alcohol‐induced Wnt signaling inhibition during bone fracture healing is normalized by intermittent parathyroid hormone treatment

Alcohol-induced Regulation of Adipogenic and Osteogenic Genes Expression of Marrow Stromal Cells

MicroRNA-223 Ameliorates Alcoholic Liver Injury by Inhibiting the IL-6–p47phox–oxidative Stress Pathway in Neutrophils

Diminished Membrane Recruitment Of Akt Is Instrumental In Alcohol-Associated Osteopenia Via The Pten/Akt/Gsk-3 Beta/Beta-Catenin Axis

Diminished membrane recruitment of Akt is instrumental in alcohol-associated osteopenia via the PTEN/Akt/GSK-3β/β-catenin axis.

Chrysophanic acid shifts the differentiation tendency of BMSCs to prevent alcohol-induced osteonecrosis of the femoral head

Chronic Alcohol Ingestion Induces Osteoclastogenesis and Bone Loss Through IL-6 in Mice

[Increasing Alcohol-Induced Osteogenesis of Human Bone Marrow-Derived Mesenchymal Cells Using Sirna Transient Suppression of Peroxisome Proliferator Activated Receptor Gamma: an in Vitro Experiment Study].

Novel Akt Activator Sc-79 is A Potential Treatment for Alcohol-Induced Osteonecrosis of the Femoral Head

The Effects of Acute and Chronic Alcohol Administration and Withdrawal on Bone Microstructure, Mechanical Strength, and Remodeling Protein Expression and Their Relation to an Antioxidant and FGF23 In Vivo